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AbstrAct
Objectives The objective was to develop and validate 
a risk model for the likelihood of extensive white matter 
lesions (extWML) to inform clinicians on whether to 
proceed with or forgo diagnostic MRI.
Design Population-based cohort study and multivariable 
prediction model.
setting Two representative samples from France.
Participants Persons aged 60–80 years without dementia 
or stroke. Derivation sample n=1714; validation sample 
n=789.
Primary and secondary outcome measures Volume of 
extWML (log cm3) was obtained from T2-weighted images 
in a 1.5 T scanner. 20 candidate risk factors for extWML 
were evaluated with the C-statistic. Secondary outcomes 
in validation included incident stroke over 12 years follow-
up.
results The multivariable prediction model included 
six clinical risk factors (C-statistic=0.61). A cut-off of 7 
points on the multivariable prediction model yielded the 
optimum balance in sensitivity 63.7% and specificity 
54.0% and the negative predictive value was high (81.8%), 
but the positive predictive value was low (31.5%). In 
further validation, incident stroke risk was associated with 
continuous scores on the multivariable prediction model 
(HR 1.02; 95% CI 1.01 to 1.04, P=0.02) and dichotomised 
scores from the multivariable prediction model (HR 1.28; 
95% CI 1.02 to 1.60, P=0.03).
conclusions A simple clinical risk equation for WML 
constituted by six variables can inform decisions whether 
to proceed with or forgo brain MRI. The high-negative 
predictive value demonstrates potential to reduce 
unnecessary MRI in the population aged 60–80 years.
IntrODuctIOn 
White matter lesions (WML) are frequently 
observed on brain MRI in the elderly 
including those without overt neurological 
symptoms. Extensive WML (extWML) pose 
as a clinical risk factor for stroke,1 2 depres-
sive symptoms,3 cognitive impairment4 
and progression to dementia.3 5 6 Intensive 
management of cardiovascular risk factors by 
primary care clinicians could mitigate further 
risk for cerebrovascular events and neuro-
cognitive disorders among persons with 
extWML. Specifically, identifying extWML 
in patients with long-standing high blood 
pressure (BP) can guide more aggressive 
BP lowering targets suggested in the PROG-
RESS trial.7 Although the pathophysiology is 
incompletely understood, WML are consid-
ered to partly reflect ischaemic small-vessel 
disease and hypoperfusion. WML association 
with vascular factors, especially hypertension, 
is commonly reported.8 9 High WML load has 
also been associated with many and some-
times conflicting risk factors.1 10–13 Given the 
breadth in possible risk factors, a challenge 
facing primary care clinicians is estimating 
the likelihood of cerebral small-vessel disease 
based on clinical factors alone when there 
is no neurological manifestation to warrant 
neuroimaging for dementia.14 
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Research
strengths and limitations of this study
 ► The study strengths include the representative 
population undergoing brain MRI, adherence 
to the transparent reporting of a multivariable 
prediction model for individual prognosis or 
diagnosis statement, examination of an exhaustive 
list of potential covariates and replication in an 
independent validation cohort.
 ► Limitations include the use of 1.5  T MRI which is 
superseded by newer generation 3 T MRI machines.
 ► In the absence of an accepted empirical definition, 
the dichotomised threshold for extensive white 
matter lesions may have led to biases in the risk 
model development.
 ► The scoring system alone cannot inform the vascular 
aetiology of dementia nor does it replace the need 
for brain imaging.
 ► Because of limited sample size and lack of precise 
dementia diagnosis in the Epidemiology of Vascular 
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Cerebral MRI is more sensitive to detect WML than 
CT15; however, it is unrealistic to perform MRI on a large 
number of older patients without overt clinical indica-
tions such as focal neurological symptoms.16 Moreover, 
access to and usage of MRI technology can be affected 
by factors such as rural location, patient health insur-
ance, MRI contraindications and the preference for 
cheaper neuroimaging techniques.17 18 Predictive clin-
ical risk scores for brain imaging are therefore of major 
interest to improve clinical decision-making and patient 
outcomes, balancing overuse and underuse of imaging. 
Cerebral imaging risk scores have guided the use of CT 
for intracranial haematoma after minor head injuries.19 20 
No risk scores exist for extWML to stratify patients least 
likely to benefit from MRI, which could offer some guid-
ance to general practitioners or at the population level 
of two-stage screening. Identifying a high likelihood 
of extWML would inform primary care management21 
and reinforce patient adherence to modifiable vascular 
risk factors.22 The objective of this study is therefore to 
develop a predictive risk score for extWML which could 
inform clinical decisions in primary care on whether to 
proceed with or forgo cerebral MRI.
MAterIAls AnD MethODs
study design and sampling
This study complies with the transparent reporting of a 
multivariable prediction model for individual prognosis 
or diagnosis (TRIPOD) statement.23 Data used for this 
study was obtained from the Three-City study (3C). The 
3C study is a French multisite prospective cohort study 
investigating the determinants of dementia, coronary 
heart disease and stroke.24 Commencing from 1999 to 
2001, the recruitment of a French population sample 
was sought for individuals who were 65 years or older at 
baseline, registered in the electoral rolls in the Dijon, 
Bordeaux and Montpelier catchment area, and able to 
provide written informed consent. Briefly, 9294 non-in-
stitutionalised community-dwelling adults aged ≥65 years 
were recruited and underwent extensive baseline exam-
inations. Serial clinic visits were scheduled at approxi-
mately 2, 4, 7 and 10 years follow-up to assess cognitive 
function, depression, incident neurological diseases and 
comorbidities. Incident stroke and dementia was assessed 
in the greater 3C cohort of persons free from dementia 
and stroke at baseline (n=8023).
The development of the extWML score was obtained 
from a subsample of participants from the city of Dijon 
who underwent brain MRI and the MRI parameters are 
described elsewhere.25 Briefly, the 3C-Dijon MRI study is 
a prospective cohort designed to study the relationship 
between vascular risk factors and diseases and the risk 
of dementia. The current analyses of extWML concern 
only the individuals who were eligible for MRI, aged less 
than 80 years and were free from dementia or stroke. 
The cohort included a mix of persons with mild cogni-
tive impairment and cognitively intact older persons. 
The study protocol has been approved by the Ethical 
Committee of the University Hospital of Kremlin-Bicêtre.
Cross validation of the model was conducted on an inde-
pendent sample of participants from the Epidemiology of 
Vascular Ageing (EVA) study.12 The cohort commenced 
in 1991 and was designed to investigate the risk factors 
for the decline in cognitive performance and the factors 
of progression of carotid atherosclerosis.12 At inclusion, 
1389 participants were recruited among elderly persons 
aged 60–70 years listed on the electoral rolls of the city 
of Nantes, France. A cerebral examination during the 
second wave of follow-up was conducted for 789 partic-
ipants to assess WML. At the second wave of follow-up, 
candidate risk factors for WML were recorded.
MrI examination
The parameters of the MRI examination in 3C have 
been reported previously.24 Briefly, all brain scans were 
acquired using the same MRI machine (1.5 T; Siemens, 
Erlangen) and the same standardised image acquisi-
tion protocol. Positioning in the magnet was based on a 
common landmark for all participants—the orbitomeatal 
line—so that the entire brain, including cerebellum and 
midbrain, was contained within the field of view of acqui-
sition. First, a three-dimensional (3D) high-resolution 
T1-weighted brain volume was acquired using a 3D inver-
sion recovery fast spoiled gradient echo sequence (3D 
SPGR; TR: 9.7 ms; TE: 4 ms; TI: 600 ms; coronal acqui-
sition). The axially reoriented 3D volume matrix size was 
256×192×256, with a voxel size of 1.0×0.98×0.98 mm3. 
Second, T2-weighted brain volumes were acquired using 
the same 2D fast spin-echo sequence with two echo times 
(TR: 4400 ms; TE1: 16 ms; TE2: 98 ms). T2 acquisition 
consisted of 35, 3.5 mm thick axial slices (with 0.5 mm 
spacing between slices), having a matrix size of 256×256, 
and an in-plane resolution of 0.98×0.98 mm2. T1 and T2 
datasets were readily reconstructed, and visually checked 
for major artefacts before further analysis. Raw data were 
converted to the ACR-NEMA standard format and then 
transformed for analysis and storage at the Department 
of Neurofunctional Imaging, Caen.
Primary outcome variable: extWMl
Fully automatic image processing software was developed 
to detect, measure and localise white matter hyperinten-
sity signals.26 With regards to location, WML located close 
to the ventricular system (10 mm distance to the ventri-
cles) were classified as periventricular. WML at a distance 
greater or equal to 10 mm to the ventricle were classified 
as deep. WML load was expressed as the total volume of 
WML normalised by the volume of the WM mask, which 
accounts both for head size and for the T2 image acquisi-
tion actual field-of-view. During development of the stan-
dardised quantification of WMLs, the automated WML 
software was compared and validated against a neurolo-
gist visual rating26 (blinded to covariates) in a subset of 
patients from 3C and EVA. This validation step used a 
modified version of the Scheltens scale27 which provides 
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Figure 1 Four T2-weighted MRI images showing the extent of white matter lesions (WML) in each quartile of total WML 
volume. The T2-weighted MRI images show four separate individuals by total WML volume, (A) first quartile of WML volume (0–
25th percentile), (B) second quartile of WML volume (26–50th percentile), (C) third quartile of WML volume (51–75th percentile), 
(D) fourth quartile of WML volume (76–100th percentile) and group denoted as having extensive WML in the logistic models. 
Light grey=white matter; dark grey=grey matter.
an overall WMH grade; none, mild, moderate, severe. 
Figure 1 displays T2-weighted MRI images depicting each 
quartile of WML.
The primary outcome variable was based on WML 
volume greater than or equal to the upper quartile that 
we considered generally representative of extWML load 
and ensured sufficient statistical power in each class. 
The WML was defined as a binary variable; 0=normal to 
low WML load (below sex-specific upper quartile) and 
1=extWML (equal or above sex-specific upper quartile; 
men (7.39 cm3), women (5.73 cm3). Age strata were: <70, 
≥70 and <75,  ≥75 years.28
secondary outcome: incident stroke
The protocol and criteria used to define prevalent and inci-
dent stroke have been previously defined.29 In Bordeaux 
and Montpellier, all subjects underwent a comprehen-
sive neuropsychological examination and were seen by a 
senior neurologist. Subjects were followed up to 12 years 
for incident stroke (fatal and non-fatal). For persons 
who reported the occurrence of vascular events during 
follow-up, further medical data were obtained from 
general practitioners, specialists and hospital records. 
The diagnosis and classification of strokes were made by 
a blinded expert panel that reviewed all existing medical 
information including, where available, cerebral imaging. 
Strokes subtypes included ischaemic and haemorrhagic 
strokes according to International Classification of 
Diseases 10th revision criteria.30
statistical methods
Potential predictors of extWML were selected based 
on published literature and study findings of 3C.1 10–13 
Other data definitions and additional statistical anal-
yses are listed in the online supplementary file. The 
risk factors tested included: age (per 1-year increase), 
marital status (married (reference), not married, sepa-
rated or widowed), education (bachelor degree (refer-
ence), no or other education), tobacco smoking status 
(none (reference), former, current), body mass index 
 
<25 kg/m² (reference), 25–30 kg/m², 30 kg/m²), 
systolic BP in mm Hg, diastolic BP in mm Hg, antihyper-
tensive drug use for hypertension, cardiovascular disease, 
acute coronary event (myocardial infarction), diabetes 
(self-report), fasting plasma glucose, ≤6 mmol/L (refer-
ence), 6.1–7.1 mmol/L, ≥7.2 mmol/L), hypercholes-
terolaemia (self-report), total cholesterol (≤6.1 mmol/L 
(reference),  7.25 mmol/L), low-density lipoprotein 
cholesterol (mmol/L), high-density lipoprotein choles-
terol (mmol/L), psychotropic drug use in the past month, 
depressive symptoms (total Center for Epidemiologi 
Studies Depression Scale score ≥16), history of lifetime 
major depression (MINI INTERNATIONAL NEURO-
PSYCHIATRIC INTERVIEW diagnosis), Mini- Mental 
State Examination (MMSE) score, Benton Visual Reten-
tion Test score, dependence in instrumental activities 
of daily living (IADL) (Lawton-Brody Scale), problems 
with balance when walking (self-report), forgetfulness, 
(self-report), difficulties retaining new simple informa-
tion (self-report), difficulties remembering old memo-
ries (self-report), difficulties with arithmetic calculations 
(self-report), difficulties with language or comprehen-
sion (self-report), difficulties with spatial orientation (eg, 
in a city street).
Candidate predictors with a probabilistic likelihood 
of extWML P<0.25 were retained for further multivar-
iate analyses. Participant age at baseline was forced 
into the initial multivariate model since age is strongly 
associated with WML.31 Thereafter age was eligible for 
elimination from the model. The optimal model for clas-
sifying extWML was computed with backward elimina-
tion to remove covariates not significantly associated with 
extWML at P<0.05 level.
The probabilistic model was evaluated based on overall 
performance, discriminatory power and calibration. 
Concordance was evaluated through the construction of 
a receiver operating characteristics curve and the C-sta-
tistic. Somer’s D provides an estimate of the difference 
between concordant and discordant pairs on a scale of 
−1 to 0, in our case between the predictive model and 
the MRI quantification of extWML. Model fit and cali-
bration was tested with the Hosmer and Lemeshow test 
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(P>0.05 implies a good fit, higher numbers signify a 
better fit). In the derivation cohort, missing data were 
handled with listwise deletion. Power calculation showed 
that a sample size of 1542 in the derivation cohort would 
provide 80% power to detect an OR of 1.35 (two-sided) 
with multiple candidate risk factors.
Deriving the prediction score
Each predictor in the probabilistic model was converted 
to a point allocation system based on the methods 
outlined by Sullivan et al,32 described in the online supple-
mentary file 1. In brain imaging studies, the potential for 
discrimination with sensitivity and specificity is weighted 
equally given the prevalence of the disease state, the 
costs of diagnostic errors and likely benefit derived to 
the patient.33 The Youden index was used to calculate the 
optimum cut-point for the score and its associated likeli-
hood ratios (LR+, LR−), positive predictive value (PPV) 
and negative predictive value (NPV). A bootstrapping 
method was used to examine the variability of the C-sta-
tistic and optimism bias or overfitting to a specific sample 
using randomly generated samples (n=1714, 17 140 and 
171 400, respectively).
cross validation
Although the sample size is large for a brain imaging 
study, it is relatively small for risk model testing. There-
fore, cross validation was performed in the independent 
EVA cohort using the scoring system from the deriva-
tion cohort. In EVA, participants with missing data were 
randomly allocated based on the proportions in 3C.
Other validation
We tested whether the extWML model derived from base-
line variables was associated with incident stroke events 
because of the close relationship between WML and 
brain outcomes. These analyses used the entire 3C cohort 
of individuals without prevalent stroke at baseline,29 
irrespective of whether participants underwent MRI. 
Incident stroke risk was analysed with Cox proportional 
hazard models showing the HR and 95% CI. The highest 
attained age was used as the time scale and participants 
were censored at the date of stroke, drop-out from the 
study or death. Analyses were adjusted for late entry bias.
results
Population characteristics
The final sample in the derivation cohort includes 1714 
participants from the 3C-Dijon MRI online supplemen-
tary e-figure 1. The sample was comprised 60.8% women 
and the median age was 72 years (IQR 69–76), 59.1% of 
subjects were married and 32.3% had completed at least 
bachelor’s level education (table 1).
White matter lesions
In the total sample, the median WML volume was 4.01 cm3 
(IQR 2.75–6.37). The WML volume differed by localisa-
tion and the median deep white matter hyperintensities 
volume was 1.16 cm3 (IQR 0.75–1.79). By contrast, in the 
periventricular region WML median volume was 2.77 cm3 
(IQR 1.82–4.65). The threshold to define extWML based 
on the global volume of WML by highest quartile and 
stratified by sex was; >6.03 cm3 for men and 4.91 cm3 for 
women. At this threshold of WML, the proportion of 
persons within each category was 168/677 men, 260/1042 
women, total 428/1719.
univariate analyses of extWMl
The univariate analysis of variables and extWML are 
reported in the online supplementary e-table 1. Variables 
significantly associated with extWML P<0.05 included 
age, diastolic BP, antihypertensive drug use, psycho-
tropic drug use, diabetes (self-reported), higher MMSE 
score, Benton Visual Retention Test score, dependence 
in IADL, calculation difficulties, forgetfulness, difficul-
ties retaining new information and gait imbalance. Other 
candidate variables at P<0.25 included systolic BP, hyper-
cholesterolaemia (self-reported), depressive symptoms on 
the CES-D and difficulties with language comprehension.
Multivariate analyses of extWMl
The final backward deletion model from multivariate 
analysis predicting extWML is presented in table 2. 
The cardiovascular covariates associated with increased 
extWML risk were diastolic BP and antihypertensive drug 
use. Other factors that emerged in the model to increase 
risk for extWML were psychotropic drug use, depen-
dence in IADL, forgetfulness and calculation difficulties. 
The Hosmer and Lemeshow test suggested an adequate 
model (P=0.88) and the diagnostic accuracy was in the 
modest range (C=0.63). The percentage of concordant 
and discordant pairs was high (62.8% vs 37.1%) with a 
small relationship between the predictive model and 
extWML (Somer’s D=0.26).
Derivation of the scoring equation
Table 3 depicts the point system to predict the likeli-
hood of extWML before MRI. extWML were predicted 
by six clinical risk factors: diastolic BP, psychotropic 
drug use, antihypertensive drug use, dependence in at 
least one IADL, forgetfulness and difficulties with simple 
arithmetic calculations. The minimum and maximum 
scores in the 3C-Dijon MRI population were −0 and 30, 
respectively, (median=7, IQR 3–10). The Hosmer and 
Lemeshow test suggested an adequate model (P=0.97). 
The C-statistic=0.61 (figure 2) suggested a limited loss of 
predictive ability with total scores versus the raw data. A 
priori risk for extWML by each level of score is presented 
in table 4 to help determine whether to perform or forgo 
brain MRI to detect WMH.
A score of 7 points on the point scoring system 
corresponded to the optimal Youden index with sensi-
tivity=63.7%, specificity 54.0%. At this score the corre-
sponding LR+=1.38, LR−=0.67, PPV=31.5% and NPV=81.8% 
for the given prevalence and threshold of extWML in 
our sample. Onlile supplementary e-table 2 describes the 
P
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Table 1 Population characteristics at baseline in the 




Median age in years, IQR 72 69–76
Married 1013 59.1
Not married 700 40.8
Bachelor degree 553 32.3
Other education 1159 67.6
BMI <25 kg/m² 841 49.0
BMI 25–30 kg/m² 677 39.5
BMI >30 kg/m² 195 11.4
Median systolic BP mm Hg, IQR 149.5 133–162.5
Median diastolic BP mm Hg, IQR 84.5 77–92
Antihypertensive drug use 730 42.6
Cardiovascular disease 71 4.1
FPG ≥7.0 mmol/L 140 8.2
Median LDL cholesterol mmol/L, 
IQR
3.53 2.99–4.06
Median HDL cholesterol mmol/L, 
IQR
1.61 1.37–1.90
Current tobacco smoker 97 5.7
Former tobacco smoker 559 32.6
Alcohol use (standard drinks per 
week), IQR
7 1–14
Psychotropic drug use 399 23.3
Depression symptoms 221 12.9
Median MMSE score, IQR 28 27–29
Median Benton score, IQR 12 11–13
Total autonomy (living 
independently)
1628 95.0
Dependence for at least one 
instrumental activity of daily living
71 4.1
Gait imbalance 332 19.4
Forgetfulness 849 49.5
Difficulties retaining new simple 
information
681 39.7
Difficulties with simple arithmetic 
calculations
275 16.1




  Median no of WML, IQR 155 120–197
  Median WML volume cm3, IQR 4.01 2.75–6.37
  Median no of deep WML, IQR 57 42–81
  Median deep WML volume cm3, 
IQR
1.16 0.75–1.79





  Median periventricular WML 
volume cm3, IQR
2.77 1.82–4.65
BMI, body mass index; BP, blood pressure; FPG, fasting plasma 
glucose; HDL, high-density lipoprotein; LDL, low-density 
lipoprotein; MMSE, Mini-Mental State Examination; WML, white 
matter lesions.
Table 1 Continued 
cumulative percent of participants with extWML at each 
level of the clinical score and the sensitivity and specificity 
values for reference purposes. Using a dichotomised score 
of 7 points only marginally reduced the C-statistic (C=0.59, 
figure 3), however, the percentage of concordant and 
discordant pairs was low (34.4% vs 16.7%) with many tied 
pairs (48.9%), resulting in lower Somer’s D=0.18. Internal 
validation with bootstrapping showed that the C-statistics 
varied minimally, between 0.57 and 0.59.
Because of the possibility that observed difficulties with 
IADL might lead to geriatrician referral and brain imaging 
later during the course of neurological disorders, we 
performed a sensitivity analysis by excluding IADL from the 
scoring system. The AUC value was marginally lower than 
the continuous score in model development (C=0.61).
cross validation
Descriptive variables used in the prediction equation 
in the 3C and EVA cohort are shown in online supple-
mentary e-table 3. Cross validation in the EVA cohort 
showed a much smaller range in scores, from 0 to 20 
points with a median of 1 (IQR 0–7). Reproducing the 
scoring system in the EVA cohort and using the dichot-
omised cut-point of 7 points obtained a very similar 
predictive value (C-statistic=0.57) suggesting high stability 
and reproducibility in an independent cohort online 
 supplementary e-figure 2
Other validation
Data were available for 8023 persons and 342 inci-
dent strokes in the larger cohort of 3C, incorporating 
Monpellier and Bordeaux participants as well as Dijon. 
The scoring system was predictive of incident stroke risk 
over 12 years using continuous (HR 1.02; 95% CI 1.01 to 
1.04, P=0.02) and dichotomised values (HR 1.28; 95% CI 
1.02 to 1.60, P=0.03).
DIscussIOn
Six clinical factors significantly predicted extWML 
detected on MRI based on sex-specific quartiles in a 
large population-based study of dementia-free older 
adults. These factors were diastolic BP, antihypertensive 
drug use, psychotropic drug use, dependence in IADL, 
forgetfulness and arithmetic difficulties. Conversion of 
these clinical variables into the scoring system produced 
modest predictive abilities for detection of extWML 
(C-statistic=0.57–63) but high NPV (82%). However, 
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Table 2 Multivariate analyses and the ORs for extensive white matter lesions (extWML) detected on MRI (n=1714)
Variable β OR 95% CI lower P value
Intercept −3.0047 – – <0.0001
Diastolic BP (per 1 mm Hg increase) 0.0156 1.016 1.006 to 1.026 0.0018
Psychotropic drug use 0.3660 1.442 1.113 to 1.868 0.0056
Antihypertensive drug use 0.5545 1.741 1.388 to 2.185 <0.0001
Dependence in at least one IADL 0.6427 1.902 1.140 to 3.171 0.0138
Forgetfulness 0.2455 1.278 1.017 to 1.607 0.0354
Difficulties with simple arithmetic calculations 0.3942 1.483 1.108 to 1.986 0.0081
The classification of extWML was based on upper quartile stratified by sex as; >6.03 cm3 for men and 4.91 cm3 for women. The regression 
model used a backward stepwise deletion procedure for covariates using a threshold for inclusion of P<0.05. 
BP, blood pressure; IADL, instrumental activities of daily living. 
sensitivity and specificity values of the scoring system 
here (63.7% and 54.0%, respectively) are very favour-
able compared with the diagnostic predictive ability to 
detect extWML with CT as reported in a recent system-
atic review.34 Cross validation in the EVA cohort provided 
comparable findings showing high consistency, reproduc-
ibility and test characteristic retention thereby pointing 
to the generalisability of the scoring system.
The final risk model here includes the cardiovas-
cular factors diastolic BP and medication use for hyper-
tension. Prior research corroborates an association 
between BP and periventricular WMLs, deep WMLs8 
and large WML load9 supporting BP as a mechanism of 
arteriolar vessel damage in the cerebral white matter. 
In terms of predictive models, a recent study elucidated 
the independent contribution of BP and other cardio-
vascular risk factors associated with WML.35 However, 
the previous study produced weighted scores from 
factor analysis which cannot be easily used by clinicians 
for risk stratification purposes. By contrast our scoring 
system can be readily used for determining extWML 
probabilities and might therefore serve to avoid unnec-
essary and costly MRI imaging. The high NPV under-
scores the clinical utility to identify persons at low risk 
of extWML.
Other risk factors associated with extWML here 
included psychotropic medication which might repre-
sent the general cerebrovascular changes evident in 
affective and neurological disorders.3 It is controver-
sial whether medications such as benzodiazepines are 
discrete risk factors or prodromal states preceding 
conversion to dementia.36 Indeed, the definition of 
psychotropic drugs here was broad, incorporating anti-
depressants, anxiolytics and neuroleptics which might 
suggest an indication bias for persons with prodromal 
dementia symptoms. Other risk factors in the scoring 
system included IADLs and it was previously docu-
mented in this sample that loss of IADLs is associated 
with mild cognitive impairment.37 It is also possible that 
some risk factors are a consequence of extWML and not 
a direct causative factor for white matter changes.
In terms of clinical implications, the predictive ability 
of the scoring system here (63.7% and 54.0%, respec-
tively) was favourable compared with external reports 
of the diagnostic predictive ability to detect WML with 
CT in a pooled review of 11 non-autopsy studies (CT 
sensitivity=71%, specificity=55%).34 These encour-
aging findings suggest minimal loss of sensitivity and 
no loss of specificity using the scoring system versus 
CT.34 The scoring system therefore has potential to 
deliver large cost savings in reducing unnecessary cere-
bral imaging for the detection of extWML as evident 
in the high NPV. Also, testament to the clinical utility 
of the scoring system, bootstrapping and cross valida-
tion in the EVA sample indicated high reproducibility 
and stability consistent with the derivation cohort. Thus 
the current findings will provide clinical utility as to 
whether clinicians should perform or forgo an MRI to 
detect extWML.
The study is presented with several strengths, including 
the large representative population size undergoing 
brain MRI, adherence to the TRIPOD statement,23 exam-
ination of an exhaustive list of potential covariates and 
replication in an independent validation cohort. The 
limitations of our study include the use of 1.5 T MRI, 
similar to other cohorts,38 which is superseded by newer 
generation 3 T MRI machines. A related point is that 
identification and quantification of WMH is commonly 
performed using parallel imaging and fluid-attenua-
tion inversion recovery (FLAIR) sequences. As parallel 
imaging and FLAIR sequences were not acquired in the 
3C study, the current findings may translate less readily 
to clinical practices or healthcare systems using such 
diagnostic methodologies. Moreover, in the absence of 
an accepted empirical definition,39 the dichotomised 
threshold for extWML may have led to biases in the 
risk model development. However, in sensitivity analysis 
reducing the extWML threshold led to a loss of predic-
tive ability. Future validation studies might therefore 
consider higher thresholds for extWML since our study 
was under powered to pursue higher thresholds. Future 
studies could grade WML according to moderate and 
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Table 3 The point scoring system based on regression 






  ≤79 mm Hg –1
  80–84 mm Hg 0
  85–89 mm Hg +1
  90–94 mm Hg +2
  95–99 mm Hg +3
  100–104 mm Hg +4
  105–109 mm Hg +5
  ≥110 mm Hg +6
Psychotropic medication use
  No psychotropic medication use 0
  Yes psychotropic medication use +5
Antihypertensive drug use
  No antihypertensive drug use 0
  Yes antihypertensive drug use +7
Dependence for ≥1 instrumental activities of daily 
living (IADL)
  Independent for IADL 0
  Yes dependence for ≥1 IADL +8
  Forgetfulness
  No forgetfulness 0
  Yes forgetfulness +3
Difficulties with simple calculations/arithmetic
  No difficulties with simple calculations/
arithmetic 0
  Yes difficulties with simple calculations/
arithmetic +5
Psychotropic medication use is inclusive of antidepressants, 
mood stabilisers, anxiolytics and neuroleptics. Antihypertensive 
drugs only included taking antihypertensive drugs explicitly for 
hypertension. IADL were measured by the Lawton-Brody scale. 
Participants were asked whether they experienced forgetfulness 
(responses dichotomised as yes or no) and had difficulties 
performing simple arithmetic calculations (responses dichotomised 
as yes or no).
Figure 2 Graph showing the area under the curve for 
the scoring system (continuous) to predict white matter 
lesions (WML) in the 3C-Dijon MRI study (n=1714). Graph 
showing the area under the curve (AUC, sensitivity and 
1-specificity) for the scoring system score to detect 
extensive WML. The scoring system is based on a point 
system derived from the regression coefficients for 
diastolic BP, antihypertensive drug use, psychotropic drug 
use, dependence in instrumental activities of daily living, 
forgetfulness and calculation difficulties. The dichotomisation 
of WML was based on sex-specific upper quartiles 
(men=6.03 cm3 and women=4.91 cm3). BP, blood pressure; 
ROC, receiver operating characteristic .
severe categories using Fazekas criteria as used in the 
Leukoaraiosis and Disability in the Elderly Study.38 
Another limitation that tempers these findings is the 
relatively modest predictive values, sensitivity and spec-
ificity, and C-statistics. This suggests that extWML are 
difficult to predict and may reflect the heterogeneity in 
extWML risk factors. Indeed, some candidate variables 
such as memory difficulties may be consequences of 
WML rather than predictive risk factors, and our study 
was not designed to distinguish between such poten-
tial bi-directional associations. Given the complexity of 
identifying risk factors for WML, the total WML load 
was calculated combining the periventricular and deep 
white matter areas whereas some risk factors are likely 
more specific to certain cerebral regions. However, 
although the scoring system did not control for location 
of WMLs the purpose here was to inform decisions on 
whether to proceed with MRI. Thus the scoring system 
alone cannot inform the vascular aetiology of dementia 
nor does it replace the need for imaging. Moreover, 
WML are heterogeneous and therefore their impact 
on cerebrovascular diseases and cognitive function may 
differ among individuals with normal ageing and those 
prone to dementia.40 41 However, because of limited 
sample size and lack of precise diagnosis in the EVA 
study, it was not possible to take this heterogeneity into 
account. Another limitation to consider is that the back-
ward deletion model may capitalise on chance variation 
within the dataset. However, the bootstrapping analysis 
showed consistency in the test score suggesting minimal 
optimism bias or overfitting to the 3C cohort. Another 
consideration for interpreting this model is the use of 
sex to derive the extWML thresholds based on previous 
findings of higher WML in women.11 This may inadver-
tently reduce the predictive power of a risk score. Also, 
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Table 4 A priori risk estimates for extensive white matter 
lesions (extWML) based on a scoring system from six 
common risk factors
Score Risk estimate Score Risk estimate
−1 14.1 17 40.1
0 15.1 18 42.0
1 16.1 19 43.9
2 17.2 20 45.9
3 18.4 21 47.8
4 19.6 22 49.8
5 20.8 23 51.7
6 22.1 24 53.7
7 23.5 25 55.6
8 24.9 26 57.5
9 26.4 27 59.4
10 28.0 28 61.3
11 29.6 29 63.1
12 31.2 30 64.9
13 32.9 31 66.7
14 34.7 32 68.4
15 36.5 33 70.0
16 38.3 34 71.6
A priori risk estimate for extWML before brain MRI based on 
the point scoring system described in table 3. The threshold 
for extWML was determined by the upper quartile stratified by 
sex as; >6.03 cm3 for men and 4.91 cm3 for women. The point 
system is further described in table 3 and is based on six clinical 
risk factors; diastolic blood pressure (5 mm Hg increments), 
psychotropic drug use, antihypertensive drug use, dependence 
in at least one instrumental activities of daily living, self-reported 
forgetfulness and self-reported difficulties with simple arithmetic 
calculations.
Figure 3 Graph showing the area under the curve 
for a dichotomised score of 7 to predict white matter 
lesions (WML) in the 3C-Dijon MRI study (n=1714). Graph 
showing the area under the curve (AUC, sensitivity and 
1-specificity) for a dichotomised score of 7 to detect 
extensive WML. The scoring system is based on a point 
system derived from the regression coefficients for 
diastolic BP, antihypertensive drug use, psychotropic drug 
use, dependence in instrumental activities of daily living, 
forgetfulness and calculation difficulties. The dichotomisation 
of WML was based on sex-specific upper quartiles 
(men=6.03 cm3 and women=4.91 cm3).  BP, blood pressure; 
ROC, receiver operating characteristic.
as this study reports the development stage, the predic-
tive ability of the scoring system requires further evalu-
ation in an external implementation study.
cOnclusIOns
A clinical risk score comprised by six factors indicated 
modest predictive ability to detect sex-specific extWML. 
Sensitivity and specificity values of the risk score were 
highly favourable compared with external imaging 
studies quantifying WML with CT.34 The C-statistics were 
stable and reproducible in bootstrapping and cross vali-
dation pointing to the generalisability of the scoring 
system. In elderly populations, the scoring system can 
inform clinical decisions on whether to proceed with or 
forgo cerebral MRI. The high-negative predictive value 
indicates that numerous costly MRIs could be avoided in 
the general population aged 65–80 years.
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